gip glp 1 agonist GIPR/GLP-1R dual therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Potential Use of GLP-1 and
Description
As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual- or tri-receptor agonists (incretin mimetics) redefine metabolic health management, oncology clinicians increasingly face questions about their use during and after active cancer treatment
Trials with no reporting on cancer-related outcomes
Hepatic fat accumulation correlates closely with visceral fat deposits, and the mechanisms that clear one tend to clear the other
We do see a lot of patients when they try to get off, unfortunately, then the weight comes back. Medi-Cal members under age 21 remain covered for purposes including weight loss, California officials said, citing a federal requirement
a classical experiment involving damaging a small part of the brain (In technical jargon, a bilateral Ventromedial hypothalamic lesion) caused rats to become morbidly obese (Pictured to the right)
The authors called for more research to flush out the effects of GLP-1 analogs on IBD versus an improvement in glycemic control
